Ohio Jury Faults Pharmacies for Spurring Opioid Epidemic

November 24, 2021 by Tom Ramstack
Ohio Jury Faults Pharmacies for Spurring Opioid Epidemic

CLEVELAND, Ohio — A landmark jury verdict Tuesday could make major pharmacy chains like CVS, Walgreens and Walmart liable for encouraging the opioid epidemic that kills thousands of Americans each year. 

The verdict in federal court in Ohio is the first to uphold a legal theory underpinning about 3,000 lawsuits nationwide.

Unlike other recent judgments in Oklahoma and California state courts, the U.S. District Court in Cleveland found that the pharmacies created a “public nuisance” by selling a dangerous drug despite its known risks of addiction, overdose and death.

If the decision survives on appeal, it would vastly increase the liability for opioid complications, according to attorneys who handled the case.

The pharmacies “engaged in intentional and/or illegal conduct [that] was a substantial factor in producing the public nuisance,” according to the verdict form. 

A separate court proceeding is scheduled for the spring to determine the penalty for the pharmacies. The plaintiffs are suggesting more than $1 billion for addiction treatment of residents in the two Ohio counties that sued.

“Today’s verdict represents a milestone victory for the Lake County and Trumbull County communities, and the entire country, in the fight against the opioid epidemic,” lawyers for the plaintiffs said in a joint statement.

Lake and Trumbull county officials blamed the pharmacies for making opioids available to consumers in amounts that far exceeded their medical needs. The pharmacies’ business practices “produced a permanent or long-lasting effect upon the public right,” their Aug. 19, 2021 court filing says. 

The trial was the first to hold pharmacies responsible for the opioid epidemic and the first that represented a victory for a local government. Other lawsuits have named opioid distributors and manufacturers as defendants.

The Oklahoma Supreme Court overturned a $465 million judgment this month against pharmaceutical company Johnson & Johnson. In California this month, a judge dismissed a lawsuit against drug manufacturers that make opioids.

All three of the pharmacies said they would appeal. They argued during the trial that they complied with all laws and Food and Drug Administration regulations.

If anyone other than the patients were to be blamed, it was the doctors, they said.

“Prescribers, they have the greatest control over the spigot,” said Brian Swanson, attorney for Walgreens, during closing arguments.

A Walgreens statement said “the trial court committed significant legal errors in allowing the case to go before a jury on a flawed legal theory that is inconsistent with Ohio law.”

A Walmart statement said the trial “was engineered to favor the plaintiffs’ attorneys and was riddled with remarkable legal and factual mistakes.”

CVS officials said they “look forward to the appeals court review of this case, including the misapplication of public nuisance law.”

Tom can be reached at [email protected].

A+
a-
  • CVS
  • pharmacies
  • Walgreens
  • Walmart
  • In The News

    Health

    Voting

    Prescription Drugs

    March 13, 2024
    by Dan McCue
    FDA Believed Poised to Approve First Med for a Serious Liver Disease

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious... Read More

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week.  Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often associated with obesity. In patients who... Read More

    March 6, 2024
    by Dan McCue
    Health Care, Drug Prices to Be Cornerstone of State of the Union

    WASHINGTON — President Joe Biden’s plans to do more to lower prescription drug prices and ensure the nation’s health care... Read More

    WASHINGTON — President Joe Biden’s plans to do more to lower prescription drug prices and ensure the nation’s health care system works better for more Americans will be the centerpiece of his State of the Union address, the White House revealed Wednesday. In a conference call... Read More

    March 4, 2024
    by Dan McCue
    Judge Rules Against Drugmaker in Price Negotiation Lawsuit

    WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a... Read More

    WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a case challenging the constitutionality of Medicare’s new drug negotiation program. The case is one of several filed by the pharmaceutical industry and its allies and the... Read More

    March 1, 2024
    by Dan McCue
    CVS, Walgreens to Begin Selling Abortion Pills Later This Month

    WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this... Read More

    WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this month, just weeks before the Supreme Court is set to hear a case that could lead to its removal from the market. The decision by both... Read More

    February 22, 2024
    by Dan McCue
    House Democrats Launch Inquiry Into Nationwide Drug Shortages

    WASHINGTON — Democrats on the House Committee on Oversight and Accountability are pressing some of the nation's largest drug manufacturers... Read More

    WASHINGTON — Democrats on the House Committee on Oversight and Accountability are pressing some of the nation's largest drug manufacturers for answers on why there are still intermittent and repeated shortages of cancer meds and other drugs. Led by Rep. Jamie Raskin, D-Md., the ranking member... Read More

    February 13, 2024
    by Dan McCue
    Federal Judge Tosses PhRMA Suit on Medicare Price Negotiations

    AUSTIN, Texas — A federal judge in Texas on Monday dismissed a PhRMA lawsuit challenging the Biden administration’s new Medicare... Read More

    AUSTIN, Texas — A federal judge in Texas on Monday dismissed a PhRMA lawsuit challenging the Biden administration’s new Medicare drug price negotiation program, a major win for the White House, though at least eight other challenges to the initiative are still pending in other courts.... Read More

    News From The Well
    scroll top